hoe 33342 and Acute Kidney Failure

hoe 33342 has been researched along with Acute Kidney Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chanvorachote, P; Chaotham, C; Ninsontia, C; Pongjit, K	1

Other Studies

1 other study(ies) available for hoe 33342 and Acute Kidney Failure

Article	Year
Silymarin selectively protects human renal cells from cisplatin-induced cell death. Pharmaceutical biology, 2011, Volume: 49, Issue:10 Topics: Acute Kidney Injury; Antineoplastic Agents; Antioxidants; Apoptosis; Benzimidazoles; Cell Death; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Formazans; Humans; Kidney; Lung Neoplasms; Melanoma; Propidium; Protective Agents; Silybum marianum; Silymarin; Tetrazolium Salts; Tumor Cells, Cultured	2011

Article

Year

Silymarin selectively protects human renal cells from cisplatin-induced cell death.

Pharmaceutical biology, 2011, Volume: 49, Issue:10

Topics: Acute Kidney Injury; Antineoplastic Agents; Antioxidants; Apoptosis; Benzimidazoles; Cell Death; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Formazans; Humans; Kidney; Lung Neoplasms; Melanoma; Propidium; Protective Agents; Silybum marianum; Silymarin; Tetrazolium Salts; Tumor Cells, Cultured

2011